TCM
Tradition Capital Management Portfolio holdings
AUM
$369M
This Quarter Return
+5.88%
1 Year Return
+6.73%
3 Year Return
+43.57%
5 Year Return
+54.57%
10 Year Return
–
AUM
$309M
AUM Growth
+$309M
(+2.2%)
Cap. Flow
-$8.11M
Cap. Flow
% of AUM
-2.63%
Top 10 Holdings %
Top 10 Hldgs %
24.11%
Holding
167
New
9
Increased
42
Reduced
79
Closed
10
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
$2.71M |
| 2 |
Citizens Financial Group
CFG
|
$2.38M |
| 3 |
Toyota
TM
|
$2.22M |
| 4 |
Novartis
NVS
|
$1.33M |
| 5 |
Devon Energy
DVN
|
$1.1M |
Top Sells
| 1 |
Lincoln Electric
LECO
|
$4.18M |
| 2 |
Fidelity National Financial
FNF
|
$2.68M |
| 3 |
Vanguard Global ex-US Real Estate ETF
VNQI
|
$1.85M |
| 4 |
Amgen
AMGN
|
$1.53M |
| 5 |
B&G Foods
BGS
|
$1.35M |
Sector Composition
| 1 | Healthcare | 21.69% |
| 2 | Financials | 20.39% |
| 3 | Consumer Discretionary | 11.39% |
| 4 | Industrials | 10.84% |
| 5 | Technology | 10.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
AbbVie
ABBV
$374B
| $10.1M | 3.28% |
113,916
-896
| -0.8% | -$79.6K |
|
2
Merck
MRK
$214B
| $8.49M | 2.75% |
132,528
-231
| -0.2% | -$14.8K |
|
3
Microsoft
MSFT
$3.75T
| $7.63M | 2.47% |
102,458
-2,925
| -3% | -$218K |
|
4
Whirlpool
WHR
$5.21B
| $7.54M | 2.44% |
40,857
+940
| +2% | +$173K |
|
5
Boeing
BA
$179B
| $7.05M | 2.28% |
27,726
-852
| -3% | -$217K |
|
6
Hanesbrands
HBI
$2.23B
| $7.03M | 2.28% |
285,235
+35,275
| +14% | +$869K |
|
7
Marsh & McLennan
MMC
$101B
| $6.92M | 2.24% |
82,597
-2,410
| -3% | -$202K |
|
|
8
Citizens Financial Group
CFG
$22.6B
| $6.59M | 2.14% |
173,995
+62,875
| +57% | +$2.38M |
|
9
3M
MMM
$82.8B
| $6.55M | 2.12% |
31,181
-6,270
| -17% | -$1.32M |
|
10
Avery Dennison
AVY
$13.4B
| $6.51M | 2.11% |
66,145
-1,182
| -2% | -$116K |
|
11
JPMorgan Chase
JPM
$829B
| $6.31M | 2.04% |
66,054
+783
| +1% | +$74.8K |
|
12
Qualcomm
QCOM
$171B
| $6.17M | 2% |
119,021
+14,475
| +14% | +$750K |
|
|
13
Novartis
NVS
$245B
| $5.9M | 1.91% |
68,729
+15,540
| +29% | +$1.33M |
|
|
14
Bristol-Myers Squibb
BMY
$96B
| $5.73M | 1.86% |
89,856
+42,495
| +90% | +$2.71M |
|
15
Abbott
ABT
$231B
| $5.6M | 1.81% |
104,856
-155
| -0.1% | -$8.27K |
|
16
Johnson & Johnson
JNJ
$427B
| $5.48M | 1.78% |
42,174
-6,606
| -14% | -$859K |
|
17
Thermo Fisher Scientific
TMO
$186B
| $5.4M | 1.75% |
28,543
-3,665
| -11% | -$693K |
|
18
Citigroup
C
$178B
| $5.37M | 1.74% |
73,828
+1,698
| +2% | +$124K |
|
19
Willis Towers Watson
WTW
$31.9B
| $5.23M | 1.69% |
33,895
+113
| +0.3% | +$17.4K |
|
20
Diageo
DEO
$61.5B
| $4.84M | 1.57% |
36,660
-4,580
| -11% | -$605K |
|
21
Medtronic
MDT
$120B
| $4.76M | 1.54% |
61,199
+335
| +0.6% | +$26.1K |
|
|
RDS.B
22
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $4.61M | 1.49% |
73,630
+1,310
| +2% | +$81.9K |
|
23
FedEx
FDX
$52.9B
| $4.24M | 1.37% |
18,809
-660
| -3% | -$149K |
|
24
Intel
INTC
$106B
| $4.24M | 1.37% |
111,245
+1,861
| +2% | +$70.9K |
|
25
Zoetis
ZTS
$69.3B
| $4.16M | 1.35% |
65,239
-1,531
| -2% | -$97.6K |
|